204 related articles for article (PubMed ID: 27835898)
21. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
[TBL] [Abstract][Full Text] [Related]
22. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
23. CXC receptor 4 and stromal cell-derived factor 1 in primary tumors and liver metastases of colorectal cancer.
Yamada S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y
J Surg Res; 2014 Mar; 187(1):107-12. PubMed ID: 24238971
[TBL] [Abstract][Full Text] [Related]
24. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway.
Liu X; Xu J; Shen B; Xu J; Jiang J
Cell Death Dis; 2023 Jun; 14(6):362. PubMed ID: 37322017
[TBL] [Abstract][Full Text] [Related]
25. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
26. [USP33 suppresses lung adenocarcinoma lung cell invasion and metastasis by down-regulating SLIT2/ROBO1 signaling pathway].
Wang Y; Zhang S; Mu S; Zhang B; Ma S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):956-961. PubMed ID: 30187867
[TBL] [Abstract][Full Text] [Related]
27. USP33 enhances cell survival and stemness by deubiquitinating CTNNB1 in BXPC-3 and SW1990 cells.
Zhong B; Zhu Q; Wang L; Wang F; Zheng Y; Lin S; Cheng X
Cell Biol Int; 2023 Aug; 47(8):1368-1380. PubMed ID: 37076992
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
[TBL] [Abstract][Full Text] [Related]
29. Lower Expression of SPRY4 Predicts a Poor Prognosis and Regulates Cell Proliferation in Colorectal Cancer.
Zhou X; Xie S; Yuan C; Jiang L; Huang X; Li L; Chen Y; Luo L; Zhang J; Wang D; Liu L; Shi W; Han L; Tang N; Ji Y
Cell Physiol Biochem; 2016; 40(6):1433-1442. PubMed ID: 27997895
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.
Zhang TT; Jiang YY; Shang L; Shi ZZ; Liang JW; Wang Z; Zhang Y; Hao JJ; Jia XM; Xu X; Cai Y; Zhan QM; Wang MR
Mol Carcinog; 2015 Oct; 54(10):1205-13. PubMed ID: 25044025
[TBL] [Abstract][Full Text] [Related]
31. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.
Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ
World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793
[TBL] [Abstract][Full Text] [Related]
32. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
[TBL] [Abstract][Full Text] [Related]
35. Determinants of survival after liver resection for metastatic colorectal carcinoma.
Parau A; Todor N; Vlad L
J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
[TBL] [Abstract][Full Text] [Related]
36. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
38. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
39. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
40. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
